BD Opens Advance Diabetes Care Headquarters in Andover, Mass.

BD expands its Massachusetts footprint with "Center of Excellence" to develop next generation technology for diabetes treatment

ANDOVER, Mass., July 15, 2015 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, officially opened its Advanced Diabetes Care facility in Andover, Mass., which will house research and development (R&D) and manufacturing of novel solutions for Type 1 and Type 2 diabetes.

"The opening of this facility represents an exciting opportunity for BD to accelerate the development of next-generation technologies to help simplify the management of Type 1 and Type 2 diabetes," said Dr. Ellen Strahlman, chief medical officer and executive vice president of Research & Development at BD. "This new model will help increase the rate of innovation and enable us to provide therapeutic advances in the diabetes care sector."

The Andover facility, which will serve as the new headquarters for BD's Advanced Diabetes Care platform, incorporates a "Center of Excellence" model, bringing R&D and manufacturing of solutions for Type 1 and Type 2 diabetes patients under one roof. The joining of multiple disciplines in one, central location allows for improved synergies in diabetes advancements. Approximately 100 associates will be located in the 75,000 square foot facility.

(L-R): Massachusetts Office of Business Development Senior Regional Director Peter Milano; Mass. State Senator Barbara L'Italian; Massachusetts Life Sciences Center Vice President Pamela Norton; BD Vice President Global Operations Jim Borzi; Mass. Assistant Secretary of Business Development Nam Pham; BD Executive Vice President R&D and Chief Medical Officer Dr. Ellen Strahlman; Town of Andover Director of Planning Paul Materazzo; BD Medical - Diabetes Care Worldwide President Ken Miller.

BD would like to recognize and thank the Massachusetts government officials and representatives of local organizations who participated in the ceremonial ribbon cutting.

About BD

BD is a leading medical technology company that partners with customers and stakeholders to address many of the world's most pressing and evolving health needs. Our innovative solutions are focused on improving medication management and patient safety; supporting infection prevention practices; equipping surgical and interventional procedures; improving drug delivery; aiding anesthesiology and respiratory care; advancing cellular research and applications; enhancing the diagnosis of infectious diseases and cancers; and supporting the management of diabetes. We are more than 45,000 associates in 50 countries who strive to fulfill our purpose of "Helping all people live healthy lives" by advancing the quality, accessibility, safety and affordability of healthcare around the world. In 2015, BD welcomed CareFusion and its products into the BD family of solutions. For more information on BD, please visit

Matt Coppola
BD Public Relations

Photo -

To view the original version on PR Newswire, visit:

SOURCE BD (Becton, Dickinson and Company)